<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03454711</url>
  </required_header>
  <id_info>
    <org_study_id>35RC17_8949_AddictO</org_study_id>
    <secondary_id>2017-A01269-44</secondary_id>
    <nct_id>NCT03454711</nct_id>
  </id_info>
  <brief_title>Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway</brief_title>
  <acronym>AddictO</acronym>
  <official_title>Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut NuMeCan, INRAE 1341</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identification of the cerebral fMRI phenotype of obese patients with FA in cognitive task&#xD;
      context based on food choice making&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is a worldwide epidemic associated with many complications. The treatment of obesity&#xD;
      is a failure if it does not take into account eating disorders. Among them, food addictions&#xD;
      seem to be frequent among obese patients. Clinical diagnosis and therapeutic approaches&#xD;
      depend on presence of these FA. Moreover, eating disorders are associated with visible brain&#xD;
      abnormalities in fMRI but the cerebral fMRI phenotype of FA is not known.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 26, 2018</start_date>
  <completion_date type="Actual">September 8, 2021</completion_date>
  <primary_completion_date type="Actual">September 8, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant change in brain activity of the prefrontal cortex (area involved in the inhibitory control of food intake) measured by modification of BOLD (Blood-Oxygen-Level-Dependent) signal in fMRI during a cognitive task based on food choice making</measure>
    <time_frame>Month 2</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients (20) will be selected from the Yale Food Addiction Scale (YFAS): a validated screening of FA questionnaire.&#xD;
Three clinical visits will be realized in less than two months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without food addictions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients (20) will be selected from the Yale Food Addiction Scale (YFAS): a validated screening of FA questionnaire.&#xD;
Three clinical visits will be realized in less than two months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Brain MRI</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Indirect calorimetry</intervention_name>
    <description>Resting energy expenditure</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioimpedance</intervention_name>
    <description>Measurement of body composition</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lipid profile, glucose, HBA1c, metabolomic analysis</intervention_name>
    <description>Blood sample</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>YFAS questionnaire, Binge Eating Scale, Hospital Anxiety and Depression (HAD) scale, hedonic evaluation test (liking)</intervention_name>
    <description>Questionnaires to characterize eating habits and depression</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  right-handed&#xD;
&#xD;
          -  grade 1 and 2 obesity&#xD;
&#xD;
          -  aged between 20 and 50&#xD;
&#xD;
          -  no other addictions including smoking&#xD;
&#xD;
          -  no contraindications to fMRI&#xD;
&#xD;
          -  affiliated to French Social Security&#xD;
&#xD;
          -  having given a written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  abdominal circumference + upper limbs along the body &gt; 200cm&#xD;
&#xD;
          -  addiction to alcohol or other psychoactive substances&#xD;
&#xD;
          -  daily smoker&#xD;
&#xD;
          -  sleep Apnea Syndrome paired&#xD;
&#xD;
          -  psychotic psychiatric disorders&#xD;
&#xD;
          -  history of bariatric surgery&#xD;
&#xD;
          -  medical care in the nutrition unit&#xD;
&#xD;
          -  inability to comprehend or complete questionnaires&#xD;
&#xD;
          -  pregnant or breastfeeding woman&#xD;
&#xD;
          -  persons subject to major legal protection (safeguarding justice, guardianship,&#xD;
             trusteeship), persons deprived of liberty.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Val-Laillet, MSc, PhD, HDR</last_name>
    <role>Study Director</role>
    <affiliation>Institut NuMeCan, INRA 1341, INSERM 1241, Universit√© de Rennes 1</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Food addictions</keyword>
  <keyword>Functional magnetic resonance imaging (fMRI)</keyword>
  <keyword>Metabolomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behavior, Addictive</mesh_term>
    <mesh_term>Food Addiction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

